X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 796 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 726-750 of 796 matching filings.

Per page
25
Current page
30
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38295

8-K

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B1 File 333-221050

424B1

Filing date
17 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-221622

S-8

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-221050

CT ORDER filing

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .